Topics

GlycoMimetics Reports First Quarter 2019 Results and Recent Operational Highlights

07:00 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Enrolled first patient in National Cancer Institute (NCI)-sponsored Phase 3 trial of uproleselan in older adults with previously untreated acute myeloid leukemia (AML) Announced plans to initiate a tr...

Other Sources for this Article

Investor Contact:
Shari Annes
Phone: 650-888-0902
Email: sannes@annesassociates.com

Media Contact:
Jamie Lacey-Moreira
Phone: 410-299-3310
Email: jamielacey@presscommpr.com

NEXT ARTICLE

More From BioPortfolio on "GlycoMimetics Reports First Quarter 2019 Results and Recent Operational Highlights"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...